Navigation Links
Painkiller Based on Sea Snail Venom Made Available in Britain

New painkiller, Prialt, based on the venom of a sea snail will be available in Britain from today.

The drug Prialt, or ziconotide, has resulted from over// 20 years' of research by the scientist, Baldomera Olivera, a professor at the University of Utah.

The advantage of Prialt is that it is 1,000 times more potent than morphine but not addictive like morphine. It is mainly aimed at people suffering from severe, chronic pain who are usually treated with morphine.

The drug is administered by injection into the fluid around the spine. It has become the first non-opioid painkiller that is administered in this method to be approved in Europe.

As many as one in seven people have been known to suffer from chronic pain. Arthritis and back pain are the commonest causes of chronic pain in addition to headache and injury.

While painkillers such as paracetamol or ibuprofen that are administered orally are the first resort those whose pain still persists can be treated with painkillers injected into the spinal fluid, using a pump worn by the patient.

Prialt is a synthetic version of the venom used by the sea snail Conus magus, popularly known as the Magician's Cone Snail, to hunt prey.

As a boy Professor Olivera used to collect the shells of these snails and study them. These two-inch sized snails shoots out a thin worm like tube into fish swimming by. When the venom is injected into the fish it is paralyzed and can be swallowed whole.

A teenager, Michael McIntosh, who started to help with the research soon after leaving school, discovered the venom. Now, 25 years later, he is a research psychiatrist at the University of Utah and still works with Professor Olivera.

On analysis of the venom they identified one peptide that stopped nerve cells from sending signals to the brain. It does this by blocking the calcium channels on the nerves, which transmit pain signals. After the channels are blo cked, calcium is unable to enter the cells, and thereby pain signals are blocked from traveling between nerve cells.

Professor Olivera believes that there are still more secrets to unravel from the sea snail. According to him there are 500 different types of these sea snails with each producing around 100 toxins in its venom. He hopes that drugs use to treat a wide range of conditions, from Parkinson's disease to depression may be derived from them.


'"/>




Related medicine news :

1. Painkillers Do Not Shorten Dying Patients Lives
2. Painkiller Linked to Deaths
3. Canine Painkiller unveiled by Novartis
4. Painkillers may protect against Alzheimers disease
5. Painkillers may raise miscarriage risk
6. Painkillers Increase Risk of Miscarriage
7. In The Habit Of Taking Painkillers For Your Chronic Headache? Time To Switch Over
8. Aspirin Might Counter Side Effects of Cox-2 Painkillers
9. Botox Can Be a Competent Painkiller
10. Painkillers Lead To Liver Failure
11. Study Advocates Use Of Oral Painkillers After Cesarean Section
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology: